nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—SLC15A1—Lisinopril—dilated cardiomyopathy	0.447	0.558	CbGbCtD
Chlorpropamide—SLC22A6—Furosemide—dilated cardiomyopathy	0.148	0.185	CbGbCtD
Chlorpropamide—ABCB1—Lisinopril—dilated cardiomyopathy	0.11	0.137	CbGbCtD
Chlorpropamide—ABCB1—Spironolactone—dilated cardiomyopathy	0.0966	0.121	CbGbCtD
Chlorpropamide—ABCC8—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0172	0.247	CbGpPWpGaD
Chlorpropamide—KCNJ11—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0167	0.24	CbGpPWpGaD
Chlorpropamide—Eruption—Furosemide—dilated cardiomyopathy	0.00582	0.0513	CcSEcCtD
Chlorpropamide—CYP2C9—cardial valve—dilated cardiomyopathy	0.00551	0.632	CbGeAlD
Chlorpropamide—Glyburide—ABCC9—dilated cardiomyopathy	0.00494	0.714	CrCbGaD
Chlorpropamide—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00462	0.0408	CcSEcCtD
Chlorpropamide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00447	0.0643	CbGpPWpGaD
Chlorpropamide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00409	0.036	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00407	0.0359	CcSEcCtD
Chlorpropamide—Drug interaction—Furosemide—dilated cardiomyopathy	0.00386	0.034	CcSEcCtD
Chlorpropamide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00343	0.0303	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00336	0.0296	CcSEcCtD
Chlorpropamide—ABCC8—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00334	0.0481	CbGpPWpGaD
Chlorpropamide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00324	0.0466	CbGpPWpGaD
Chlorpropamide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00312	0.0275	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00306	0.027	CcSEcCtD
Chlorpropamide—ABCC8—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00297	0.0426	CbGpPWpGaD
Chlorpropamide—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00289	0.0255	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00288	0.0254	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00275	0.0243	CcSEcCtD
Chlorpropamide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00261	0.023	CcSEcCtD
Chlorpropamide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00257	0.0227	CcSEcCtD
Chlorpropamide—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00255	0.0225	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0023	0.0203	CcSEcCtD
Chlorpropamide—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00222	0.0196	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00216	0.019	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00205	0.0181	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00203	0.0179	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.002	0.0176	CcSEcCtD
Chlorpropamide—Probenecid—SLC22A5—dilated cardiomyopathy	0.00198	0.286	CrCbGaD
Chlorpropamide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00196	0.0173	CcSEcCtD
Chlorpropamide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00187	0.0165	CcSEcCtD
Chlorpropamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00186	0.0164	CcSEcCtD
Chlorpropamide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0017	0.015	CcSEcCtD
Chlorpropamide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00167	0.0147	CcSEcCtD
Chlorpropamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00166	0.0146	CcSEcCtD
Chlorpropamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00161	0.0142	CcSEcCtD
Chlorpropamide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0016	0.0141	CcSEcCtD
Chlorpropamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00155	0.0137	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00154	0.0136	CcSEcCtD
Chlorpropamide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00149	0.0132	CcSEcCtD
Chlorpropamide—Rash—Spironolactone—dilated cardiomyopathy	0.00148	0.0131	CcSEcCtD
Chlorpropamide—Headache—Spironolactone—dilated cardiomyopathy	0.00147	0.013	CcSEcCtD
Chlorpropamide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0014	0.0124	CcSEcCtD
Chlorpropamide—Leukopenia—Furosemide—dilated cardiomyopathy	0.0014	0.0124	CcSEcCtD
Chlorpropamide—Nausea—Spironolactone—dilated cardiomyopathy	0.00139	0.0123	CcSEcCtD
Chlorpropamide—ABCC8—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00132	0.019	CbGpPWpGaD
Chlorpropamide—KCNJ11—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00128	0.0184	CbGpPWpGaD
Chlorpropamide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00127	0.0112	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00125	0.011	CcSEcCtD
Chlorpropamide—Anorexia—Furosemide—dilated cardiomyopathy	0.00122	0.0107	CcSEcCtD
Chlorpropamide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00111	0.00979	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0011	0.00972	CcSEcCtD
Chlorpropamide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00105	0.00927	CcSEcCtD
Chlorpropamide—Urticaria—Furosemide—dilated cardiomyopathy	0.00101	0.00895	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000938	0.00827	CcSEcCtD
Chlorpropamide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000913	0.00805	CcSEcCtD
Chlorpropamide—Pruritus—Furosemide—dilated cardiomyopathy	0.000903	0.00797	CcSEcCtD
Chlorpropamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000896	0.0129	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000873	0.00771	CcSEcCtD
Chlorpropamide—Dizziness—Furosemide—dilated cardiomyopathy	0.000844	0.00745	CcSEcCtD
Chlorpropamide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000843	0.00744	CcSEcCtD
Chlorpropamide—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000838	0.012	CbGpPWpGaD
Chlorpropamide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000833	0.00735	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000827	0.0073	CcSEcCtD
Chlorpropamide—Vomiting—Furosemide—dilated cardiomyopathy	0.000812	0.00716	CcSEcCtD
Chlorpropamide—Rash—Furosemide—dilated cardiomyopathy	0.000805	0.0071	CcSEcCtD
Chlorpropamide—Headache—Furosemide—dilated cardiomyopathy	0.0008	0.00706	CcSEcCtD
Chlorpropamide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000761	0.00671	CcSEcCtD
Chlorpropamide—Nausea—Furosemide—dilated cardiomyopathy	0.000758	0.00669	CcSEcCtD
Chlorpropamide—KCNJ11—heart—dilated cardiomyopathy	0.00074	0.0848	CbGeAlD
Chlorpropamide—ABCC8—heart—dilated cardiomyopathy	0.000682	0.0781	CbGeAlD
Chlorpropamide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000678	0.00598	CcSEcCtD
Chlorpropamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000655	0.00578	CcSEcCtD
Chlorpropamide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000633	0.00559	CcSEcCtD
Chlorpropamide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000609	0.00537	CcSEcCtD
Chlorpropamide—KCNJ11—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.000608	0.00873	CbGpPWpGaD
Chlorpropamide—Rash—Lisinopril—dilated cardiomyopathy	0.000604	0.00533	CcSEcCtD
Chlorpropamide—Headache—Lisinopril—dilated cardiomyopathy	0.0006	0.00529	CcSEcCtD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000591	0.00849	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—ABCC9—dilated cardiomyopathy	0.000577	0.00829	CbGpPWpGaD
Chlorpropamide—Nausea—Lisinopril—dilated cardiomyopathy	0.000569	0.00502	CcSEcCtD
Chlorpropamide—KCNJ11—Neuronal System—ABCC9—dilated cardiomyopathy	0.000559	0.00804	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—ACTN2—dilated cardiomyopathy	0.000553	0.00794	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000548	0.00788	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—ACTN2—dilated cardiomyopathy	0.000536	0.0077	CbGpPWpGaD
Chlorpropamide—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000534	0.00767	CbGpPWpGaD
Chlorpropamide—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000411	0.0059	CbGpPWpGaD
Chlorpropamide—SLC15A2—heart—dilated cardiomyopathy	0.000407	0.0467	CbGeAlD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000407	0.00585	CbGpPWpGaD
Chlorpropamide—PTGS1—myocardium—dilated cardiomyopathy	0.000399	0.0457	CbGeAlD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000354	0.00508	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000343	0.00493	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000334	0.00479	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000334	0.00479	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00031	0.00446	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000309	0.00444	CbGpPWpGaD
Chlorpropamide—CYP2C9—heart—dilated cardiomyopathy	0.000305	0.0349	CbGeAlD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0003	0.00431	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0003	0.00431	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000286	0.00412	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000279	0.00401	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000279	0.004	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000279	0.004	CbGpPWpGaD
Chlorpropamide—PTGS1—heart—dilated cardiomyopathy	0.000278	0.0319	CbGeAlD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000274	0.00393	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000261	0.00375	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000259	0.00372	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000254	0.00365	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000239	0.00343	CbGpPWpGaD
Chlorpropamide—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000238	0.0273	CbGeAlD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000237	0.00341	CbGpPWpGaD
Chlorpropamide—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000237	0.0034	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000225	0.00324	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	0.000219	0.00314	CbGpPWpGaD
Chlorpropamide—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000216	0.0031	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000213	0.00306	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—TAZ—dilated cardiomyopathy	0.000212	0.00304	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000207	0.00297	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000207	0.00297	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	0.000205	0.00295	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.0002	0.00287	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000192	0.00276	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—SDHA—dilated cardiomyopathy	0.000192	0.00275	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	0.000186	0.00267	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000167	0.0024	CbGpPWpGaD
Chlorpropamide—ABCB1—heart—dilated cardiomyopathy	0.000164	0.0188	CbGeAlD
Chlorpropamide—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000156	0.00224	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.00015	0.00216	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000146	0.0021	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000138	0.00198	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000134	0.00192	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—RAF1—dilated cardiomyopathy	0.000126	0.00181	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000126	0.0018	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	0.000122	0.00175	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000113	0.00163	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000106	0.00153	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000104	0.00149	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.69e-05	0.00139	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	9.62e-05	0.00138	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.42e-05	0.00135	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.42e-05	0.00135	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.76e-05	0.00126	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	7.68e-05	0.0011	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	7.4e-05	0.00106	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	7.26e-05	0.00104	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.76e-05	0.000972	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	6.52e-05	0.000937	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	6.37e-05	0.000915	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	6.37e-05	0.000915	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	6.13e-05	0.000881	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.09e-05	0.000875	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.99e-05	0.00086	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	5.95e-05	0.000855	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.87e-05	0.000843	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.71e-05	0.000821	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.65e-05	0.000812	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	5.59e-05	0.000804	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	5.55e-05	0.000797	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	5.41e-05	0.000778	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—GPX1—dilated cardiomyopathy	5.21e-05	0.000748	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.15e-05	0.000739	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—CD36—dilated cardiomyopathy	5.07e-05	0.000728	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	5.06e-05	0.000727	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	5.05e-05	0.000725	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	4.92e-05	0.000706	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.81e-05	0.000691	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—AGT—dilated cardiomyopathy	4.56e-05	0.000656	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	4.43e-05	0.000636	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.2e-05	0.000603	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.38e-05	0.000486	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.3e-05	0.000474	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.29e-05	0.000473	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.14e-05	0.000452	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.08e-05	0.000443	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3e-05	0.000432	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.97e-05	0.000426	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.7e-05	0.000389	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	2.61e-05	0.000375	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CD36—dilated cardiomyopathy	2.54e-05	0.000366	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—AGT—dilated cardiomyopathy	2.29e-05	0.000329	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.91e-05	0.000275	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.51e-05	0.000216	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.47e-05	0.000211	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.47e-05	0.000211	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.43e-05	0.000206	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.37e-05	0.000197	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.34e-05	0.000192	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.32e-05	0.00019	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.29e-05	0.000185	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.2e-05	0.000173	CbGpPWpGaD
